FLPUTNAM INVESTMENT MANAGEMENT CO
Position in CRDF — Cardiff Oncology, Inc.
CIK 1140334
PORTLAND, ME
Position in CRDF
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$964,105
-$708,766 QoQ
Shares Held
595,127
-0.0% QoQ
Ownership
0.870%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in CRDF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FLPUTNAM INVESTMENT MANAGEMENT CO holds $37,680,376 across 10 Biotechnology names. CRDF ranks #5 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
39,498 | $17,637,436 | |
| 2 | TRVI |
Trevi Therapeutics, Inc.
|
1,063,301 | $12,685,180 | |
| 3 | ZVRA |
Zevra Therapeutics, Inc.
|
350,501 | $3,266,669 | |
| 4 | KZIA |
Kazia Therapeutics Ltd
|
142,469 | $1,059,969 | |
| 5 | CRDF |
Cardiff Oncology, Inc.
This page
|
595,127 | $964,105 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,741 | $906,914 | |
| 7 | GNLX |
GENELUX Corp
|
280,904 | $679,787 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
454 | $350,778 |
All Filings in CRDF
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $964,105 | 595,127 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,672,871 | 595,328 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,230,299 | 597,233 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $169,668 | 53,863 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||